Washington [US], July 28 (ANI): A new class of glioma medications takes advantage of tumours lacking the DNA repair enzyme MGMT; the medications cause the generation of cytotoxic DNA and kill tumour cells specifically without the risk of developing resistance, according to research.
London [UK], October 21 (ANI): Scientists studying the most common and aggressive type of brain tumour in adults have discovered a new way of analysing diseased and healthy cells from the same patient.
\
\
\
\
